Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40537 NEUEHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 47-4991296 (State or othe ...

NeueHealth (NEUE) Q2 2025 Earnings Call August 07, 2025 08:00 AM ET Speaker0Good morning. Thank you for attending today's conference call. My name is Jerry, and I will be your moderator today. All lines will be muted during the presentation portion of the call. I would now like to pass the conference over to our host, Emily Long.Speaker1Good morning, and welcome to Health's Second Quarter twenty twenty five Earnings Conference Call. As a reminder, this call is being recorded. Leading the call today are New ...

Exhibit 99.1 Key Metrics | | As of June 30, | | | --- | --- | --- | | | 2025 | 2024 | | Consumer and Patient Metrics | | | | Value-Based Consumers served | 546,000 | 364,000 | | Enablement Services Lives | 148,000 | 113,000 | | ($ in thousands) | Three Months Ended | | | | Six Months Ended | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | June 30, | | | | June 30, | | | | | | 2025 | | 2024 | | 2025 | | | 2024 | | Financial Metrics | | | | | | | | | | Revenue | $ | 209,082 $ | | 225,991 | $ ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40537 NEUEHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 47-4991296 (State or oth ...

Financial Data and Key Metrics Changes - New Health reported consolidated revenue of $215.8 million for Q1 2025, slightly lower than the previous year due to a shift in membership mix [9] - The first quarter gross margin was $54.9 million, and the company achieved adjusted EBITDA profitability for the fifth consecutive quarter, generating $13.5 million in adjusted EBITDA [9][10] Business Line Data and Key Metrics Changes - In the New Care segment, revenue was $90.5 million with an operating income of $23 million, serving 530,000 value-based consumers, representing a 67% increase over 2024 [10] - The New Solutions segment generated revenue of $127.6 million but reported an operating loss of $3 million, serving 138,000 consumers in the provider enablement business [10] Market Data and Key Metrics Changes - The company served over 709,000 consumers in Q1 2025, reflecting a growth of approximately 51% compared to Q1 2024 [4][10] - The diverse population base served across the ACA marketplace, Medicare, and Medicaid is critical for mitigating risks associated with high concentration in any one product area [6] Company Strategy and Development Direction - The company aims to continue advancing its value-driven consumer-centric care model, expanding its capabilities, and deepening partnerships with providers and payers [7][14] - Key growth areas include serving a diverse population, expanding in existing markets, and forming new relationships with payer groups [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's strong position to continue driving value for consumers, providers, and payers, and highlighted the importance of trust-based relationships [5][7] - The anticipated transaction to go private, led by NEA, is expected to close in mid-2025, pending necessary conditions [7] Other Important Information - As of March 31, 2025, the company had total cash and investments of $239.4 million, with non-regulated cash and short-term investments at $145.1 million [11] Q&A Session Summary - No specific questions and answers were provided in the content, thus this section is not applicable.

NeueHealth (NEUE) Q1 2025 Earnings Call May 08, 2025 08:00 AM ET Speaker0 Good morning, and welcome to New Health's First Quarter twenty twenty five Earnings Conference Call. As a reminder, this call is being recorded. Leading the call today are New Health's President and CEO, Mike Mikan and CFO, Jay Matuszak. Before we begin, we want to remind you that this call may contain forward looking statements under U. S. Federal securities laws. These statements are subject to risks and uncertainties that could cau ...

NeueHealth First Quarter 2025 - Earnings Presentation Privileged & Confidential | © 2024 May 8, 2025 Disclaimer Statements made in this presentation that are not statements of historical fact, including statements about our beliefs and expectations, are forward-looking statements and should be evaluated as such. Forward-looking statements include information concerning possible or assumed future results of operations, including descriptions of our business plan and strategies, as well as statements regardin ...

Exhibit 99.1 DORAL, Fla. (May 8, 2025) (BUSINESSWIRE) – NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE: NEUE), the value- driven healthcare company, today reported financial results for its first quarter ended March 31, 2025. "We are starting 2025 in a very strong position, generating substantial growth in the number of consumers we serve and delivering another quarter of Adjusted EBITDA profitability," said Mike Mikan, President and CEO of NeueHealth. "Our value-driven, consumer-centric care model ...

FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NEUEHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 47-4991296 (State or other jurisdiction of incorporation or organization) 9250 NW 36th St Suite 420, Doral, FL 33178 (Address of principal executive offices) (Zip Code) Registrant's telepho ...

NeueHealth, Inc (NYSE:NEUE) Q4 2024 Results Conference Call March 20, 2025 8:00 AM ET Company Participants Emily Lombardi - Assistant Vice President Mike Mikan - President & Chief Executive Officer Jay Matushak - Chief Financial Officer Operator Good morning, and thank you for joining us for the NeueHealth Q4 2024 Earnings Conference Call. My name is Carlin. I'll be coordinating the call today. And I'd like to hand over to your host, Emily Lombardi. The floor is yours. Emily Lombardi Good morning, and welco ...